Clinical pharmacokinetics of metformin.

@article{Graham2011ClinicalPO,
  title={Clinical pharmacokinetics of metformin.},
  author={Garry G Graham and Jeroen Punt and Manit Arora and Richard O. Day and Matthew P. Doogue and J K Duong and Timothy John Furlong and Jerry R Greenfield and Louise C Greenup and Carl M. J. Kirkpatrick and John E. Ray and Peter Timmins and Kenneth Mapson Williams},
  journal={Clinical pharmacokinetics},
  year={2011},
  volume={50 2},
  pages={81-98}
}
Metformin is widely used for the treatment of type 2 diabetes mellitus. It is a biguanide developed from galegine, a guanidine derivative found in Galega officinalis (French lilac). Chemically, it is a hydrophilic base which exists at physiological pH as the cationic species (>99.9%). Consequently, its passive diffusion through cell membranes should be very limited. The mean ± SD fractional oral bioavailability (F) of metformin is 55 ± 16%. It is absorbed predominately from the small intestine… CONTINUE READING
Highly Influential
This paper has highly influenced 23 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 191 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 101 references

Metformin kinetics in healthy subjects and inpatientswith diabetesmellitus.Br JClin Pharmacol

  • GT Tucker, C Casey, PJ Phillips
  • 1981
Highly Influential
12 Excerpts

Similar Papers

Loading similar papers…